Le Lézard
Classified in: Health, Business
Subjects: MAV, LBR, PSF

/R E P E A T -- Media Advisory: Public Health Ontario Lab workers are sounding the alarm - rural families are at risk!/


TORONTO, April 16, 2024 /CNW/ - OPSEU/SEFPO President JP Hornick and members working at Public Health Ontario (PHO) Labs will join NDP MPPs Jamie West and Monique Taylor on Wednesday April 17 in the morning for a news conference at Queen's Park to sound the alarm about the potential closure of six (6) out of 11 PHO labs in Ontario, and the risk it poses for rural families and communities.

PHO currently has a plan to close the laboratory sites in Timmins, Sault Ste. Marie, Orillia, Hamilton, Kingston, and Peterborough as part of its 'modernization plan'. In December 2023, the Auditor General endorsed this plan and recommended that the labs be closed within 12 months.

Combined, these labs collect and process thousands of water samples and time-sensitive medical tests each day. They are integral to our public health infrastructure in Ontario.

The closure of these 6 community-based PHO labs will increase health inequities and endanger rural families and communities. It will also undermine our ability to detect and prevent the spread of disease and compromise our response to future health crises.

Workers at the affected lab sites and members of their communities launched a petition campaign to stop the closures and will deliver thousands of signatures to Queen's Park. The event coincides with National Medical Laboratory Week, where we recognize the important role these professionals have in promoting the health and safety of everyone in Ontario.

OPSEU/SEFPO calls on the Ford Government to stop the closure of the six labs and invest in the public health infrastructure needed to keep Ontarians safe and healthy.

What: News conference and petition delivery
When: Wednesday April 17, 9:30 am 
Where: Queen's Park Media Studio
Guest Dial-in Numbers:
Local - Toronto, (+1) 416 764 8658 
Toll Free - North America, (+1) 888 886 7786

Livestream link:

https://www.ola.org/en/legislative-business/video/media-studio 

Media availability:

JP Hornick, OPSEU/SEFPO President
Casey McGuire, PHO Lab worker and OPSEU/SEFPO Blood Services and Diagnostics sector executive member
Geoffrey Cain, OPSEU/SEFPO Blood Services and Diagnostics sector chair
MPP Jamie West
MPP Monique Taylor

SOURCE Ontario Public Service Employees Union (OPSEU/SEFPO)


These press releases may also interest you

at 06:05
Aurinia Pharmaceuticals Reports First Quarter 2024 Financial and Operational Results
Aurinia Pharmaceuticals Inc. (Aurinia or the Company) today issued its financial results for the first quarter ended March 31, 2024. Amounts are expressed in U.S. dollars. Total net revenue was $50.3 million for the three months ended March 31,...

at 06:00
Isarna Therapeutics Announces Phase 2 Clinical Data Presentations at Upcoming Ophthalmology Conferences
Isarna Therapeutics today announced upcoming oral presentations at the OIS Retina Innovation Summit on May 4th and the Association for Research in Vision and Ophthalmology (ARVO) Meeting on May 7th, both in Seattle, WA. Isarna's Chief Medical...

at 06:00
U.S. Dermatology Partners and UT Tyler School of Medicine Partner Together to Bring Dermatology Education to East Texas
U.S. Dermatology Partners and The University of Texas at Tyler School of Medicine are proud to announce their partnership in establishing a new Department of Dermatology. This collaboration aims to improve the health and well-being of East Texans...

at 06:00
MARPAI INC. ANNOUNCES COST REDUCTION PROGRAM AND PROPERTY SUBLEASE
Marpai, Inc. ("Marpai" or the "Company") , an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced...

at 06:00
PainTEQ Receives Two New Patents for the LinQ Procedure, Advancing Treatments for SI Joint Dysfunction
In a significant advancement for minimally invasive pain management, PainTEQ has been awarded two new patents for its pioneering LinQ® procedure, further solidifying its position as a leader in sacroiliac (SI) joint dysfunction treatment. These...

at 06:00
Genomenon Partners with Pharming to Advance APDS Diagnosis
Genomenon, a genomic intelligence company, has partnered with Pharming Group in an effort to make variant data on the PIK3CD and PIK3R1 genes available to genetic testing labs, as well as clinicians and researchers, worldwide. This data enables...

More news about Health...


News published on and distributed by: